article · Reproductive Health

Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments

Mohamed Afifi
Laurence Läser
Hanan Hasan
Raza Zaidi
Alissar Rady
Rachid Bezad
H. Emad Al-Masri
Rana Hajjeh
Buthaina Ghanem
Nilmini Hemachandra
Khalid Kadhem Al-Kinani
Qudsia Uzma
Ulrika Rehnström Loi
Al-Umra Umar
Dima M. Qato
Itimad Abu Ward
Mohamed Hashem
Amine Cheikh
Paata Chikvaidze
Ellen Thom
Sabeen Afzal
Omelkheir Brngali
Ubah Farah
Qais Sikandar
Zahir Sidiqui Abdul
Yusuf Omar Mohamed
Hafid Hachri
Raghad A. Abbas
Zakri Abu Qamar
Ali Nashat Shaar
Faysal El‐Kak
Maha El‐Adawy

20241 citationOpen accessMohammed V University

Abstract

These findings can guide efforts aimed at improving the availability of Mifepristone, Misoprostol, and contraceptive medicines in the Eastern Mediterranean Region. Opportunities include expanding national EMLs to include more options for Mifepristone, Misoprostol, and contraceptive medicines and strengthening the registration and procurement systems to ensure these medicines' availability were permitted under national law and where culturally acceptable.

Research topics

Global Maternal and Child Health
Pharmaceutical Economics and Policy
Reproductive Health and Contraception

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12978-024-01805-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.